RNA immunoprecipitation (RIP) was performed using the EZ-Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore, Billerica, MA, http://www.emdmillipore.com/) according to the manufacturer’s protocol [42]. The direct binding of miRNA-mediated RNA-induced silencing complex (RISC) to HCV RNA was determined using anti-Ago2 antibody (Abcam, Cambridge, MA, http://www.abcam.com/) mediated RNA pulldown followed by quantitative polymerase chain reaction (qPCR) examine the amount of HCV RNA. In brief, 70%–80% confluence cells were washed twice with PBS and trypsinized. Cells were lysed and centrifuged at 12,000 rpm for 10 minutes at 4°C. Cell lysate was incubated with antibody/beads for 18 hours at 4°C. After incubation, beads were washed three times in NT2 buffer (50 mM Tris-HCl, 300 mM NaCl, 1 mM MgCl2, 0.05% Nonidet P-40, RNase inhibitor), followed by treated with DNase I for 15 minutes at 37°C. RNAs were extracted by RNA purification kit (RNeasy MiniElute kit, Qiagen, Hilden, Germany, https://www.qiagen.com) and cDNA was synthesized using the SuperScript kit (Thermo Fisher Scientific Life Sciences) and the quality of cDNA was analyzed by qPCR.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.